Ken Fisher’s Vaxart VXRT Stock Holding History

Ken Fisher’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,069	Closed	-$4.55K	–	1088
2025 Q2	$4.55K	Buy	10,069 +69	+0.7%	+$30	﹤0.01%	986
2025 Q1	$4.07K	Sell	10,000 -25	-0.2%	-$16	﹤0.01%	998
2024 Q4	$6.64K	Sell	10,025 -25	-0.2%	-$17	﹤0.01%	974
2024 Q3	$8.53K	Sell	10,050 -220	-2%	-$168	﹤0.01%	918
2024 Q2	$6.85K	Buy	+10,270	New	+$8.53K	﹤0.01%	982

Other funds holding VXRT

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HSA

HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

CFO

Custos Family Office Austin, Texas $147M AUM 17.83% 1-Year Est. Return

LCM

LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return

HWA

Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Ken Fisher's VXRT Position: Q3 2025 in Review

Ken Fisher sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 10,069 shares — an estimated $4.55K sold.

Ken Fisher first reported a position in VXRT in Q2 2024 and held it in 5 quarters. The position peaked at $8.53K in Q3 2024. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

Ken Fisher reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
Ken Fisher sold 10,069 Vaxart shares in Q3 2025, an estimated $4.55K.
Ken Fisher first reported a position in Vaxart in Q2 2024 and held it in 5 quarters.
Ken Fisher's Vaxart position peaked at $8.53K in Q3 2024.
17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Fisher Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.